U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07547761) titled 'NOBO Body Odor Control Efficacy Proof-of-Concept Study #1' on April 17.
Brief Summary: The goal of this clinical trial is to evaluate the performance of NOBO, a yeast-based fermentate designed to control axillary odor, in controlling axillary odor in healthy male and female adults age 18 - 70 with confirmed self-perception of body odor. The main question it aims to answer is:
Does NOBO decrease self-perceived odor of the intervention axilla compared to the placebo axilla at any time point? Researchers will compare the intervention axilla to the placebo axilla to see if there is a difference in self-perceived odor and microbiome.
...